Met Life Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 73,011 shares of VRTX stock, worth $29.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
73,011
Previous 74,839 2.44%
Holding current value
$29.8 Million
Previous $35.1 Million 3.2%
% of portfolio
0.2%
Previous 0.21%

Shares

79 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $840,880 - $924,565
-1,828 Reduced 2.44%
73,011 $34 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $1.87 Million - $2.31 Million
4,749 Added 6.78%
74,839 $35.1 Million
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $28.6 Million - $31.3 Million
70,090 New
70,090 $29.3 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $474,369 - $567,970
-1,383 Reduced 1.88%
72,271 $29.4 Million
Q3 2023

May 09, 2024
SELL
$338.18 - $362.46 $779,843 - $835,832
-2,306 Reduced 3.04%
73,654 $25.6 Million
Q3 2023

Apr 29, 2024
SELL
$338.18 - $362.46 $522,149 - $559,638
-1,544 Reduced 2.05%
73,654 $25.6 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $522,149 - $559,638
-1,544 Reduced 2.05%
73,654 $25.6 Million
Q2 2023

Apr 29, 2024
BUY
$314.42 - $351.91 $23.6 Million - $26.5 Million
75,198 New
75,198 $26.5 Million
Q2 2023

Aug 10, 2023
SELL
$314.42 - $351.91 $239,588 - $268,155
-762 Reduced 1.0%
75,198 $26.5 Million
Q1 2023

May 09, 2024
BUY
$283.23 - $323.1 $21.5 Million - $24.5 Million
75,960 New
75,960 $23.9 Billion
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $191,463 - $218,415
-676 Reduced 0.88%
75,960 $23.9 Million
Q4 2022

May 10, 2024
SELL
$285.76 - $321.48 $413,494 - $465,181
-1,447 Reduced 1.85%
76,636 $22.1 Million
Q4 2022

Jun 14, 2023
BUY
$285.76 - $321.48 $193,173 - $217,320
676 Added 0.89%
76,636 $22.1 Million
Q4 2022

Mar 22, 2023
SELL
$285.76 - $321.48 $413,494 - $465,181
-1,447 Reduced 1.85%
76,636 $22.1 Million
Q4 2022

Feb 15, 2023
SELL
$285.76 - $321.48 $413,494 - $465,181
-1,447 Reduced 1.85%
76,636 $22.1 Million
Q3 2022

May 10, 2024
SELL
$273.83 - $305.53 $194,693 - $217,231
-711 Reduced 0.9%
78,083 $22.6 Million
Q3 2022

Jun 14, 2023
BUY
$273.83 - $305.53 $581,341 - $648,640
2,123 Added 2.79%
78,083 $22.6 Million
Q3 2022

Mar 22, 2023
SELL
$273.83 - $305.53 $194,693 - $217,231
-711 Reduced 0.9%
78,083 $22.6 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $194,693 - $217,231
-711 Reduced 0.9%
78,083 $22.6 Million
Q2 2022

May 10, 2024
BUY
$234.96 - $292.55 $1.17 Million - $1.45 Million
4,969 Added 6.73%
78,794 $22.2 Million
Q2 2022

Jun 20, 2023
BUY
$234.96 - $292.55 $665,876 - $829,086
2,834 Added 3.73%
78,794 $22.2 Million
Q2 2022

Mar 22, 2023
BUY
$234.96 - $292.55 $1.17 Million - $1.45 Million
4,969 Added 6.73%
78,794 $22.2 Million
Q2 2022

Aug 11, 2022
BUY
$234.96 - $292.55 $1.17 Million - $1.45 Million
4,969 Added 6.73%
78,794 $22.2 Million
Q1 2022

May 10, 2024
BUY
$221.42 - $260.97 $16.3 Million - $19.3 Million
73,825 New
73,825 $19.3 Million
Q1 2022

Jun 20, 2023
SELL
$221.42 - $260.97 $472,731 - $557,170
-2,135 Reduced 2.81%
73,825 $19.3 Million
Q1 2022

Mar 22, 2023
BUY
$221.42 - $260.97 $3.91 Million - $4.61 Million
17,650 Added 31.42%
73,825 $19.3 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $3.91 Million - $4.61 Million
17,650 Added 31.42%
73,825 $19.3 Million
Q4 2021

May 17, 2024
SELL
$177.01 - $223.45 $428,187 - $540,525
-2,419 Reduced 4.13%
56,175 $12.3 Million
Q4 2021

Jun 21, 2023
SELL
$177.01 - $223.45 $3.5 Million - $4.42 Million
-19,785 Reduced 26.05%
56,175 $12.3 Million
Q4 2021

Mar 22, 2023
SELL
$177.01 - $223.45 $976,033 - $1.23 Million
-5,514 Reduced 8.94%
56,175 $12.3 Million
Q4 2021

Feb 15, 2022
SELL
$177.01 - $223.45 $976,033 - $1.23 Million
-5,514 Reduced 8.94%
56,175 $12.3 Million
Q3 2021

May 17, 2024
SELL
$181.39 - $202.99 $257,936 - $288,651
-1,422 Reduced 2.37%
58,594 $10.6 Million
Q3 2021

Jun 21, 2023
SELL
$181.39 - $202.99 $3.15 Million - $3.53 Million
-17,366 Reduced 22.86%
58,594 $10.6 Million
Q3 2021

Mar 22, 2023
BUY
$181.39 - $202.99 $303,465 - $339,602
1,673 Added 2.79%
61,689 $11.2 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $303,465 - $339,602
1,673 Added 2.79%
61,689 $11.2 Million
Q2 2021

May 17, 2024
SELL
$187.49 - $221.1 $362,418 - $427,386
-1,933 Reduced 3.12%
60,016 $12.1 Million
Q2 2021

Jun 21, 2023
SELL
$187.49 - $221.1 $2.99 Million - $3.53 Million
-15,944 Reduced 20.99%
60,016 $12.1 Million
Q2 2021

Mar 22, 2023
SELL
$187.49 - $221.1 $362,418 - $427,386
-1,933 Reduced 3.12%
60,016 $12.1 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $362,418 - $427,386
-1,933 Reduced 3.12%
60,016 $12.1 Million
Q1 2021

May 17, 2024
SELL
$207.02 - $241.31 $1.69 Million - $1.96 Million
-8,141 Reduced 11.62%
61,949 $13.3 Million
Q1 2021

Jun 26, 2023
SELL
$207.02 - $241.31 $2.9 Million - $3.38 Million
-14,011 Reduced 18.45%
61,949 $13.3 Billion
Q1 2021

Mar 22, 2023
SELL
$207.02 - $241.31 $248,838 - $290,054
-1,202 Reduced 1.9%
61,949 $13.3 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $248,838 - $290,054
-1,202 Reduced 1.9%
61,949 $13.3 Million
Q4 2020

May 24, 2024
SELL
$207.01 - $276.09 $598,051 - $797,624
-2,889 Reduced 4.37%
63,151 $14.9 Million
Q4 2020

Jun 22, 2023
SELL
$207.01 - $276.09 $2.65 Million - $3.54 Million
-12,809 Reduced 16.86%
63,151 $14.9 Million
Q4 2020

Mar 22, 2023
SELL
$207.01 - $276.09 $598,051 - $797,624
-2,889 Reduced 4.37%
63,151 $14.9 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $598,051 - $797,624
-2,889 Reduced 4.37%
63,151 $14.9 Million
Q3 2020

May 24, 2024
SELL
$255.65 - $303.1 $452,756 - $536,790
-1,771 Reduced 2.61%
66,040 $18 Billion
Q3 2020

Jun 26, 2023
SELL
$255.65 - $303.1 $2.54 Million - $3.01 Million
-9,920 Reduced 13.06%
66,040 $18 Million
Q3 2020

Mar 22, 2023
SELL
$255.65 - $303.1 $452,756 - $536,790
-1,771 Reduced 2.61%
66,040 $18 Million
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $452,756 - $536,790
-1,771 Reduced 2.61%
66,040 $18 Million
Q2 2020

May 24, 2024
SELL
$225.48 - $295.8 $513,868 - $674,128
-2,279 Reduced 3.25%
67,811 $19.7 Billion
Q2 2020

Jun 26, 2023
SELL
$225.48 - $295.8 $1.84 Million - $2.41 Million
-8,149 Reduced 10.73%
67,811 $19.7 Million
Q2 2020

Mar 22, 2023
BUY
$225.48 - $295.8 $344,307 - $451,686
1,527 Added 2.3%
67,811 $19.7 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $344,307 - $451,686
1,527 Added 2.3%
67,811 $19.7 Million
Q1 2020

Jul 12, 2023
SELL
$199.77 - $247.81 $1.93 Million - $2.4 Million
-9,676 Reduced 12.74%
66,284 $15.8 Million
Q1 2020

Mar 22, 2023
SELL
$199.77 - $247.81 $405,133 - $502,558
-2,028 Reduced 2.97%
66,284 $15.8 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $405,133 - $502,558
-2,028 Reduced 2.97%
66,284 $15.8 Million
Q4 2019

Jul 12, 2023
SELL
$166.71 - $223.91 $1.27 Million - $1.71 Million
-7,648 Reduced 10.07%
68,312 $15 Million
Q4 2019

Mar 22, 2023
SELL
$166.71 - $223.91 $272,904 - $366,540
-1,637 Reduced 2.34%
68,312 $15 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $272,904 - $366,540
-1,637 Reduced 2.34%
68,312 $15 Million
Q3 2019

Jul 12, 2023
SELL
$166.23 - $187.09 $999,208 - $1.12 Million
-6,011 Reduced 7.91%
69,949 $11.9 Million
Q3 2019

Mar 22, 2023
SELL
$166.23 - $187.09 $107,717 - $121,234
-648 Reduced 0.92%
69,949 $11.9 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $107,717 - $121,234
-648 Reduced 0.92%
69,949 $11.9 Million
Q2 2019

Jul 12, 2023
SELL
$164.61 - $190.37 $882,803 - $1.02 Million
-5,363 Reduced 7.06%
70,597 $12.9 Million
Q2 2019

Mar 22, 2023
SELL
$164.61 - $190.37 $341,730 - $395,208
-2,076 Reduced 2.86%
70,597 $12.9 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $341,730 - $395,208
-2,076 Reduced 2.86%
70,597 $12.9 Million
Q1 2019

Jul 13, 2023
SELL
$163.73 - $194.7 $538,180 - $639,978
-3,287 Reduced 4.33%
72,673 $13.4 Million
Q1 2019

Mar 22, 2023
SELL
$163.73 - $194.7 $67,293 - $80,021
-411 Reduced 0.56%
72,673 $13.4 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $67,293 - $80,021
-411 Reduced 0.56%
72,673 $13.4 Million
Q4 2018

Jul 13, 2023
SELL
$151.91 - $192.21 $436,893 - $552,795
-2,876 Reduced 3.79%
73,084 $12.1 Million
Q4 2018

Mar 22, 2023
SELL
$151.91 - $192.21 $191,254 - $241,992
-1,259 Reduced 1.69%
73,084 $12.1 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $191,254 - $241,992
-1,259 Reduced 1.69%
73,084 $12.1 Million
Q3 2018

Jul 13, 2023
SELL
$167.73 - $192.74 $271,219 - $311,660
-1,617 Reduced 2.13%
74,343 $14.3 Million
Q3 2018

Mar 22, 2023
SELL
$167.73 - $192.74 $384,604 - $441,952
-2,293 Reduced 2.99%
74,343 $14.3 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $112,882 - $129,714
-673 Reduced 0.9%
74,343 $14.3 Million
Q2 2018

Aug 15, 2018
SELL
$145.72 - $169.96 $202,550 - $236,244
-1,390 Reduced 1.82%
75,016 $12.8 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $279,550 - $326,627
-1,844 Reduced 2.36%
76,406 $12.5 Million
Q4 2017

Feb 15, 2018
BUY
$137.28 - $155.55 $10.7 Million - $12.2 Million
78,250
78,250 $11.7 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email